ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, will host ...

Insulet experienced a 12% decline in its stock price over the past week following its earnings announcement and corporate guidance. The company reported strong year-over-year sales growth, however ...

Insulet develops, manufactures, and markets the Omnipod Insulin Management System for people that have diabetes. This system is worn on the body for approximately three days at a time and allows ...

Insulet stock opened at $270.81 on Tuesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.80 and a current ratio of 3.68. The firm has a market cap of $19.02 billion, a P/E ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

March 18, 2025 • Derek Thompson, staff writer at The Atlantic, author of the "Work in Progress" newsletter and host of the podcast "Plain English," and Ezra Klein, New York Times opinion ...

WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

Sadly, those accounts didn't start pouring in until after she was dead. Federal investigators concluded that Brian killed Gabby in August 2021, less than two months into their odyssey. Though the ...

Insulet (PODD) has disclosed a new risk, in the Natural and Human Disruptions category. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving strong buy ratings from ...